TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study.

Tycel Jovelle Phillips et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.